Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant-Reference-Cited by-同舟云学术

Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant

Published:2005-04-20 Issue:1 Volume:3 Page:
ISSN:1476-8518
Container-title:Journal of Immune Based Therapies and Vaccines
language:en
Short-container-title:J Immune Based Ther Vaccines

Author:

Ruiz Wanda,McClements William L,Jansen Kathrin U,Esser Mark T

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1186/1476-8518-3-2.pdf

Reference34 articles.

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.

2. Eiben GL, da Silva DM, Fausch SC, Le Poole IC, Nishimura MI, Kast WM: Cervical cancer vaccines: recent advances in HPV research. Viral Immunol. 2003, 16: 111-121. 10.1089/088282403322017866.

3. Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002, 97: 72-81. 10.1002/ijc.1571.

4. Laukkanen P, Koskela P, Pukkala E, Dillner J, Laara E, Knekt P, Lehtinen M: Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol. 2003, 84: 2105-2109. 10.1099/vir.0.18995-0.

5. zur Hausen H: Viruses in human cancers. Science. 1991, 254: 1167-1173.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A reactogenic “placebo” and the ethics of informed consent in Gardasil HPV vaccine clinical trials: A case study from Denmark;International Journal of Risk & Safety in Medicine;2024-05-31

2. Characterization of the early cellular immune response induced by HPV vaccines;Frontiers in Immunology;2022-07-18

3. Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine;Frontiers in Immunology;2020-07-10

4. A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques;Journal of Virology;2020-04-16

5. Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types;Expert Review of Vaccines;2019-03-04